Back to search

United States· US:41250-123_28f01088-048a-ba28-e063-6394a90a0acb

Effervescent Orange Cold Relief

A medicinal product containing phenylephrine bitartrate; aspirin; chlorpheniramine maleate, registered in United States by Meijer Distribution Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedEffervescent Orange Cold ReliefATC—REGISTER NO.US:41250-123_28f01088…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PHENYLEPHRINE BITARTRATE; ASPIRIN; CHLORPHENIRAMINE MALEATE
Manufacturer
Meijer Distribution Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    4125012320
    10 POUCH in 1 CARTON (41250-123-20) / 2 TABLET, EFFERVESCENT in 1 POUCH
  • ndc11
    4125012324
    12 POUCH in 1 CARTON (41250-123-24) / 2 TABLET, EFFERVESCENT in 1 POUCH
  • ndc11
    41250-123-20
  • ndc11
    41250-123-24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phenylephrine bitartrate; aspirin; chlorpheniramine maleate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenylephrine bitartrate; aspirin; chlorpheniramine maleate products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Spain · Aspirina Complex, Couldina
  • Poland · Polopiryna Complex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e77bc68f-f5de-41a6-87bb-085e8910370c
GET /v1/drugs/e77bc68f-f5de-41a6-87bb-085e8910370c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "7.8; 325; 2",
  "substance": "PHENYLEPHRINE BITARTRATE; ASPIRIN; CHLORPHENIRAMINE MALEATE",
  "productndc": "41250-123",
  "dosage_form": "TABLET, EFFERVESCENT",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1; mg/1",
  "application_number": "M012",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about phenylephrine bitartrate; aspirin; chlorpheniramine maleate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.